PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jptmJournal of Pathology and Translational MedicineThis ArticleAims and ScopeInstructions for Authorse-Submission
 
J Pathol Transl Med. 2017 March; 51(2): 180–184.
Published online 2017 February 13. doi:  10.4132/jptm.2016.08.30
PMCID: PMC5357754

Mucinous Cystadenoma of the Testis: A Case Report with Immunohistochemical Findings

Abstract

Mucinous cystadenoma of the testis is a very rare tumor. Herein, we report a case of mucinous cystadenoma arising in the testis of a 61-year-old man, along with a literature review. Computed tomography showed a 2.5-cm-sized poorly enhancing cystic mass. Grossly, the tumor was a unilocular cystic mass filled with mucinous material and confined to the testicular parenchyma. Histologically, the cyst had a fibrotic wall lined by mucinous columnar epithelium without atypia. Immunohistochemical staining was positive for cytokeratin 20 and CDX2, as well as focally positive for cytokeratin 7. The pathologic diagnosis was mucinous cystadenoma.

Keywords: Testis, Cystadenoma, mucinous, Immunohistochemistry

Testicular/paratesticular tumors resembling mucinous or serous ovarian tumors are rare; between the two subtypes, mucinous neoplasms are less commonly reported than serous neoplasms [1-7]. To our knowledge, there have been approximately 24 case reports of mucinous neoplasms of the testis or paratestis, and only four cases of “testicular mucinous cystadenoma” were found in the English-language literature (Table 1) [1,2,8-11]. In Korea, two cases of mucinous cystadenomas of the paratestis or spermatic cord have been reported [4,7]. However, there has been no published report of testicular mucinous cystadenoma in Korea. Here, we report a case of mucinous cystadenoma in the parenchyma of a testis.

Table 1.
Cases of primary testicular mucinous cystadenoma

CASE REPORT

A 61-year-old Korean man presented with a painless right testicular mass. Serum tumor markers including β-human chorionic gonadotrophin, α-fetoprotein, and lactate dehydrogenase were within normal limits. Urine cytology was negative for malignant cells. Computed tomography (Fig. 1A) and ultrasound (Fig. 1B) imaging showed a 2.5-cm-sized poorly enhancing cystic mass at the right testis. Radical orchiectomy was performed.

Fig. 1.
Representative images of radiologic and macroscopic findings of a right testicular mass. Computed tomography (A) and ultrasound imaging (B) present a cystic mass (arrow in A) suspected to have a tumorous condition. (C) Surgical specimen reveals a mass ...

Pathological examination demonstrated that the cystic mass was confined within the testicular parenchyma, with a size of 2.5×2.4×1.7 cm. On macroscopic examination, the mass had a unilocular cavity filled with mucinous materials (Fig. 1C). The cyst wall was composed of thick fibrous tissue. There was no solid or papillary growth or calcification in the cyst.

Microscopically, the cyst was surrounded by a thick fibrous wall and was filled with mucinous material (Fig. 2AC). The cyst had a single layer of columnar mucinous epithelial cells without nuclear atypia (Fig. 2D). Stromal mucin spillage was found around the tumor with inflammatory cell infiltration (Fig. 2E). The inflammatory cells were composed of lymphocytes, plasma cells, and histiocytes (Fig. 2F). There was no hemorrhage, necrosis, or calcification. Teratomatous elements, such as cartilage, bone, or other mesenchymal teratomatous components, were not found. Squamous epithelium and intratubular germ cell neoplasia were also absent. Mitotic figures were not observed. Microscopically, the tumor was limited to the testicular parenchyma without involvement of the tunica albuginea.

Fig. 2.
Microscopic findings of the mucinous cystadenoma of the testis. (A) The tumor has a uniloculated cyst with an expanding growth pattern. (B) The cyst is surrounded by a thick fibrous capsule, and there are some inflammatory cells around the tumor. (C) ...

Immunohistochemically, the lining epithelial cells were positive for cytokeratin 20 (CK20) (Fig. 3A) and CDX2 (Fig. 3C), as well as focally positive for cytokeratin 7 (CK7) (Fig. 3B). The cells were negative for PAX-8 (Fig. 3D), D2-40, WT-1, and cytokeratin 5/6 (CK5/6). Calretinin was weakly positive in cytoplasm.

Fig. 3.
Immunohistochemical staining results. The lining cells are positive for cytokeratin 20 (A), focally positive for cytokeratin 7 (B), positive for CDX2 (C), and negative for PAX8 (D).

This study was approved by the Institutional Review Board (IRB) of Seoul National University Hospital.

DISCUSSION

Mucinous neoplasms of the testis or paratestis are rare and not well described in the medical literature [8,12]. The first reported case of mucinous neoplasm was mucinous cystadenoma in the paratestis of an 11-year-old boy by Kellert in 1959 [1]. To date, most reported testicular/paratesticular ovarian-type surface epithelial neoplasms have been of the “serous” subtype [5,13,14], and “intratesticular” neoplasms have rarely been reported [12]. Previous papers reported approximately 24 cases of mucinous neoplasms of the testis or paratestis; among these, only four reports described “testicular mucinous cystadenoma” excluding the present case [1,2,8,9]. In the Korean literature, three cases of serous borderline tumors of the testis/paratestis and two cases of paratesticular mucinous cystadenomas were found, but there has been no report of any “mucinous cystadenoma of the testicular parenchyma” to date [3-7].

The histologic features of mucinous cystadenomas of the testis resemble those of common ovarian mucinous cystadenomas [1,2]. That is, the cyst is typically composed of mucinous epithelium with tall, columnar endocervical-like cells lacking nuclear atypia [15]. However, there are several histologic differences between testicular mucinous cystadenomas and ovarian mucinous cystadenomas. Testicular mucinous cystadenomas are generally not as large as ovarian tumors, purportedly because the testicular tumors are found by patients earlier than their ovarian counterparts due to the sites at which the tumors arise. Testicular tumors are more often unilocular and more frequently exhibit mucus extravasation associated with fibrosis or calcification than ovarian tumors, possibly because of trauma due to their superficial location [15].

The origin of testicular mucinous neoplasms has not yet been clarified; thus, several hypotheses have been suggested. Ulbright and Young [15] supported the theory that the tumors arise from metaplasia of the mesothelium of the visceral tunica vaginalis. Another theory, suggested by Shimbo et al. [2], is that inflammation results in mesothelial introduction into the testicle and mucinous metaplasia. The theory that the tumors arise from the remnants of the Müllerian ducts persisting in the male appendix, testis, or extratesticular scrotal contents is considered the most reasonable by some researchers [8,16]. Others have postulated the possibility of one-sided teratoma cell differentiation [9,15,17].

Differential diagnoses include testicular mucinous borderline neoplasms/carcinomas, germ cell tumors, mesotheliomas, and metastatic mucinous tumors [15]. In comparison with mucinous borderline tumors or mucinous carcinomas, mucinous cystadenomas lack the atypia of tumor cells [8,15]. Testicular mucinous carcinomas or borderline neoplasms have been reported more frequently than testicular mucinous cystadenomas. To date, seven mucinous borderline neoplasms and four mucinous carcinomas have been reported [1,8]. It is also important to rule out germ cell tumors, for example, teratomas with prominent mucinous components. Teratomas are known to occur in patients with a median age of 23–29 years. Teratomas almost always have components other than mucinous epithelial lined cysts, and 90% of those tumors occurring in adults are accompanied by intratubular germ cell neoplasia of unclassified type [15]. Unlike testicular mucinous cystadenomas, mesotheliomas exhibit positivity for calretinin, which is known to be expressed in mesothelial cells [10]. Pathologists must consider metastatic mucinous tumors. The appropriate immunohistochemical staining, cytologic atypia, and history of mucinous carcinoma are critical for determining the origin of the tumor.

The immunohistochemical profile of the tumor has not been specified until now [8]. However, in several reports, testicular mucinous neoplasms have shown immunostaining that is positive for both CK7 and CK20 or positive for CK20 and negative for CK7 [8]. The present case showed positive staining for CK20 and focal positive staining for CK7, a result similar to previous studies. Additionally, the present case also showed positive staining for CDX2 and negative staining for PAX8, D2-40, and CK5/6. Calretinin immunostaining was weak only in the cytoplasm. CDX2 is known to be useful in distinguishing primary ovarian mucinous tumors from metastases of lower gastrointestinal tract origin [18]. There has been only one case report of CDX2 expression in testicular or paratesticular mucinous neoplasms, revealing CDX2-positive and PAX8-negative staining [4]. Together with the results of this report, testicular or paratesticular mucinous tumors may express CDX2. Immunohistochemical results for calretinin, CK5/6, D2-40, and PAX8 suggest that testicular mucinous cystadenoma does not originate from mesothelium or Müllerian duct remnants, while the results support the possibility of monodermal teratoma differentiation.

Although only a small number of testicular mucinous cystadenomas have been reported, these reported cases have shown good prognosis, similar to the prognosis of ovarian mucinous cystadenomas [1].

In conclusion, mucinous cystadenoma of the testis is an extremely rare benign tumor and likely expresses CDX2.

Footnotes

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Elliott JE, Klein JR, Drachenberg DE. Primary testicular mucinous neoplasms: case report and literature review. Can Urol Assoc J. 2010;4:E112–5. [PMC free article] [PubMed]
2. Shimbo M, Araki K, Kaibuchi T, Kuramochi H, Mori I. Mucinous cystadenoma of the testis. J Urol. 2004;172:146–7. [PubMed]
3. Park KM, Cho NB, Song KY. A serous papillary cystadenoma of low malignant potential in paratesticular tissue. Korean J Pathol. 1996;30:463–5.
4. Kim JY, Lee YT, Kang HJ, Lee CH. Primary mucinous cystadenoma of the spermatic cord within the inguinal canal. Diagn Pathol. 2012;7:139. [PMC free article] [PubMed]
5. Park MI, Kim HS, Suh KS, Kang DY. Paratesticular papillary serous tumor of low malignant potential: a case report. Korean J Pathol. 2004;38:427–9.
6. Park HJ, Park SW, Chon WH, Jung SG, Park NC. A serous papillary cystadenoma of borderline malignancy in testis. Korean J Androl. 2007;25:36–8.
7. Weon HC, Kim IS, Jang CS, Hong SJ, Lee MS. Papillary mucinous cystadenoma, paratesticular: a case report. Korean J Urol. 1986;27:359–60.
8. Celdran JO, Rodriguez CS, Valverde FM, Compiano LO. Primary mucinous cystadenocarcinoma of the testis: an extremely rare ovarian-type surface epithelial carcinoma. J Cancer Res Ther. 2015;11:647. [PubMed]
9. Nokubi M, Kawai T, Mitsu S, Ishikawa S, Morinaga S. Mucinous cystadenoma of the testis. Pathol Int. 2002;52:648–52. [PubMed]
10. Naito S, Yamazumi K, Yakata Y, et al. Immunohistochemical examination of mucinous cystadenoma of the testis. Pathol Int. 2004;54:355–9. [PubMed]
11. Alasio TM, Borin J, Taylor K, Bar-Chama N, Unger PD. Intratesticular mucinous cystadenoma: immunohistochemical comparison with ovarian and colonic tissue. Arch Pathol Lab Med. 2005;129:399–402. [PubMed]
12. Burger T, Schildhaus HU, Inniger R, et al. Ovarian-type epithelial tumours of the testis: immunohistochemical and molecular analysis of two serous borderline tumours of the testis. Diagn Pathol. 2015;10:118. [PMC free article] [PubMed]
13. Olla L, Di Naro N, Puliga G, Tolu GA. Intraparenchymal serous papillary cystadenoma of the testis: a case report. Pathologica. 2013;105:15–7. [PubMed]
14. Remmele W, Kaiserling E, Zerban U, et al. Serous papillary cystic tumor of borderline malignancy with focal carcinoma arising in testis: case report with immunohistochemical and ultrastructural observations. Hum Pathol. 1992;23:75–9. [PubMed]
15. Ulbright TM, Young RH. Primary mucinous tumors of the testis and paratestis: a report of nine cases. Am J Surg Pathol. 2003;27:1221–8. [PubMed]
16. Amin MB. Selected other problematic testicular and paratesticular lesions: rete testis neoplasms and pseudotumors, mesothelial lesions and secondary tumors. Mod Pathol. 2005;18 Suppl 2:S131–45. [PubMed]
17. Young RH, Scully RE. Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and mullerian types: a report of four cases and review of the literature. Am J Clin Pathol. 1986;86:146–52. [PubMed]
18. Vang R, Gown AM, Wu LS, et al. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Mod Pathol. 2006;19:1421–8. [PubMed]

Articles from Journal of Pathology and Translational Medicine are provided here courtesy of Korean Society of Pathologists and Korean Society for Cytopathology